4-(4,4-difluoropiperidin-1-yl)-3-(trifluoromethyl)benzonitrile

Catalog No.: 
ACGCZV337
CAS No.: 
1311255-54-5
Molecular Formula: 
C13H11F5N2
Molecular Weight: 
290.23
4-(4,4-difluoropiperidin-1-yl)-3-(trifluoromethyl)benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4,4-difluoropiperidin-1-yl)-3-(trifluoromethyl)benzonitrile
IUPAC Name4-(4,4-difluoropiperidin-1-yl)-3-(trifluoromethyl)benzonitrile
Molecular FormulaC13H11F5N2
Molecular Weight290.23
SMILESN#CC1=CC(C(F)(F)F)=C(N2CCC(F)(F)CC2)C=C1
InChI KeyUKUNRZDMKYWBTR-UHFFFAOYSA-N
Synonym4-(4,4-Difluoropiperidin-1-yl)-3-(trifluoromethyl)benzonitrile;Benzonitrile, 4-(4,4-difluoro-1-piperidinyl)-3-(trifluoromethyl)-;4-(4,4-Difluoro-1-piperidinyl)-3-(trifluoromethyl)benzonitrile
CAS No.1311255-54-5

Synthetic Route by SureRoute

1. ACGCZV337 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFGCD759 route compound structure diagram
    ACFGCD759144230-52-4In Stock
  2. Plus
  3. ACADBF368 route compound structure diagram
    ACADBF36867515-59-7In Stock
  4. Then
  5. ACGCZV337 route product structure diagram
    ACGCZV3371311255-54-5
Inquiry

2. ACGCZV337 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACGCZV337 route product structure diagram
    ACGCZV3371311255-54-5
Inquiry

3. ACGCZV337 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFGCD759 route compound structure diagram
    ACFGCD759144230-52-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGCZV337 route product structure diagram
    ACGCZV3371311255-54-5
Inquiry

Comments (0)